Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models
Obesity and type 2 diabetes mellitus (T2DM) are preconditions for the development of metabolic syndrome, which is reaching pandemic levels worldwide, but there are still only a few anti-obesity drugs available. One of the promising tools for the treatment of obesity and related metabolic complicatio...
Guardado en:
Autores principales: | Lucia Mráziková, Barbora Neprašová, Anna Mengr, Andrea Popelová, Veronika Strnadová, Lucie Holá, Blanka Železná, Jaroslav Kuneš, Lenka Maletínská |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3912e19852a7429d857bae0d25a4764e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structurally conserved C-RFa revealed prolactin releasing activity in vitro and gene expression changes in pituitary of seasonally acclimatized carp
por: Romero,Alex, et al.
Publicado: (2012) -
Evidence of a role for prolactin as regulators of ovarian follicular development in goose
por: Ma,Rong, et al.
Publicado: (2015) -
Prolactin-Induced Adaptation in Glucose Homeostasis in Mouse Pregnancy Is Mediated by the Pancreas and Not in the Forebrain
por: Zin Khant Aung, et al.
Publicado: (2021) -
The Prolactin Family of Hormones as Regulators of Maternal Mood and Behavior
por: Teodora Georgescu, et al.
Publicado: (2021) -
A reduction in voluntary physical activity in early pregnancy in mice is mediated by prolactin
por: Sharon R Ladyman, et al.
Publicado: (2021)